VALsartan in Acute myocardial iNfarcTion (VALIANT) trial
Jump to navigation
Jump to search
Introduction
Increased risk of death after myocardial infarction in patients with diabetes mellitus (newly diagnosed or established)
RR = 1.4-1.5 &
for cardiovascular events within 1 year, RR = 1.3-1.4
More general terms
References
- ↑ Journal Watch 24(22):167, 2004 Aguilar D, Solomon SD, Kober L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004 Sep 21;110(12):1572-8. Epub 2004 Sep 13. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15364810